THU164 Design Of The New InsiGHTS Trial: A Multicenter, Phase 2, Randomized, Open-label, Active Controlled Study To Investigate The Safety, Tolerability, And Efficacy Of Lonapegsomatropin In Prepubertal Individuals With Turner Syndrome

Disclosure: K.O. Klein: Advisory Board Member; Self; Abbvie, Tolmar. Consulting Fee; Self; Abbvie, Tolmar. Grant Recipient; Self; Arbor. Research Investigator; Self; Abbvie, Arbor. Speaker; Self; Abbvie. P. Backeljauw: Advisory Board Member; Self; Ascendis Pharma. Consulting Fee; Self; Novo Nordisk,...

Descripción completa

Detalles Bibliográficos
Autores principales: Klein, Karen O, Backeljauw, Philippe, Abdelrahman, Sohair, Lai, Pamela, Mao, Meng, Shu, Aimee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Pediatric Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555881/
http://dx.doi.org/10.1210/jendso/bvad114.1415

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555881/
http://dx.doi.org/10.1210/jendso/bvad114.1415

Ejemplares similares